Showing results (501-510 of 1,609) with videos related to

Sort By:
Pageof 161
JAMA Oncology|December 9, 2016
Effect of Standard Radiotherapy With Cisplatin vs Accelerated Radiotherapy With Panitumumab in Locoregionally Advanced Squamous Cell Head and Neck Carcinoma: A Randomized Clinical TrialLillian L Siu, John N Waldron, Bingshu E Chen, et al.
JAMA Oncology|November 29, 2016
Surveillance Mammography in Older Patients With Breast Cancer-Can We Ever Stop?: A ReviewRachel A Freedman, Nancy L Keating, Ann H Partridge, et al.
JAMA Oncology|November 29, 2016
Lymphadenectomy for Treatment of Early-Stage Endometrial CancerJonathan A Frost, Katie E Webster, Jo Morrison
JAMA Oncology|November 29, 2016
Targeting the PI3K/AKT/mTOR Pathway for the Treatment of Mesenchymal Triple-Negative Breast Cancer: Evidence From a Phase 1 Trial of mTOR Inhibition in Combination With Liposomal Doxorubicin and BevacizumabReva K Basho, Michael Gilcrease, Rashmi K Murthy, et al.
JAMA Oncology|January 27, 2017
Association of Dietary Patterns With Risk of Colorectal Cancer Subtypes Classified by Fusobacterium nucleatum in Tumor TissueRaaj S Mehta, Reiko Nishihara, Yin Cao, et al.
JAMA Oncology|January 27, 2017
Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical TrialGabriel N Hortobagyi, Catherine Van Poznak, W Graydon Harker, et al.
JAMA Oncology|January 19, 2017
Surrogate End Points for All-Cause Mortality in Men With Localized Unfavorable-Risk Prostate Cancer Treated With Radiation Therapy vs Radiation Therapy Plus Androgen Deprivation Therapy: A Secondary Analysis of a Randomized Clinical TrialTrevor J Royce, Ming-Hui Chen, Jing Wu, et al.
JAMA Oncology|January 19, 2017
Molecular-Based Recursive Partitioning Analysis Model for Glioblastoma in the Temozolomide Era: A Correlative Analysis Based on NRG Oncology RTOG 0525Erica Hlavin Bell, Stephanie L Pugh, Joseph P McElroy, et al.
JAMA Oncology|January 24, 2017
Frequency of Thyroid Carcinoma in Brazilian TP53 p.R337H Carriers With Li Fraumeni SyndromeMaria Nirvana da Cruz Formiga, Kelvin César de Andrade, Luiz Paulo Kowalski, et al.
JAMA Oncology|March 22, 2019
Effect of Taxane Plus Platinum Regimens vs Doxorubicin Plus Cisplatin as Adjuvant Chemotherapy for Endometrial Cancer at a High Risk of Progression: A Randomized Clinical TrialHiroyuki Nomura, Daisuke Aoki, Hirofumi Michimae, et al.
Pageof 161